New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024 09:15 ET
|
FN Media Group LLC
PALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The SARS-CoV-2, literally affected the whole world in these past years and has increased a global search for...
COVID-19 Vaccines Business Research Report 2024: Doses to Reach a Projected 4.2 Billion by 2025 - Global Market Forecast to 2030
August 28, 2024 04:45 ET
|
Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for COVID-19...
Triyam Recognized on Inc. 5000 List for the Fourth Consecutive Year
August 15, 2024 09:00 ET
|
Access Information Management Shared Services, LLC
Company ranking leveled up 999 spots on this highlighted list of America’s Fastest-Growing Private Companies
A Monthly Review of How COVID-19 Impacts the Diagnostics, Therapeutics, and Vaccines Market
July 22, 2024 04:25 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Monthly Snapshot" newsletter has been added to ResearchAndMarkets.com's offering. The newsletter provides a detailed analysis of the impact...
AvePoint Named to Inc.’s Annual List of Best Workplaces for 2024
June 18, 2024 08:45 ET
|
AvePoint, Inc.
JERSEY CITY, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in robust data management and data governance, today announced it has been named to Inc.’s annual Best...
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting
May 20, 2024 06:35 ET
|
Shah Capital
Welcomes Recent Announcement by Novavax of Licensing Agreement with Sanofi Stresses Significant Value Still Remains to Be Unlocked at Novavax Still Believes Novavax Would Benefit from Stockholder...
Global Preventive Vaccines Market Size To Exceed USD 101.22 Billion By 2033 | CAGR Of 1.37%
May 13, 2024 10:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, May 13, 2024 (GLOBE NEWSWIRE) -- The Global Preventive Vaccines Market Size is to Grow from USD 88.34 Billion in 2023 to USD 101.22 Billion by 2033, at a Compound Annual...
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting
May 06, 2024 06:22 ET
|
Shah Capital
Highlights Novavax’s Massive Untapped Value That it Believes is Being Hindered by an Overly Conservative Board and Management That Clings to Failed Strategies and Have Undermined Stockholder Value ...
Global COVID-19 Vaccines Research Report 2023-2025 - Licensing and Partnership Deals Worldwide Propel Vaccine Production
April 22, 2024 06:22 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global COVID-19 Vaccines Market to...
RSV Vaccine Market To Reach USD 2.2 Billion By 2032 | DataHorizzon Research
April 18, 2024 06:10 ET
|
DataHorizzon Research
Fort Collins, Colorado, April 18, 2024 (GLOBE NEWSWIRE) -- Growing prevalence of RSV in the population drives the need for RSV vaccines. RSV, a prevalent respiratory virus, often leads to severe...